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Purpose: Several dietary factors have been associated with glaucoma. Among them, dietary antioxidant intake (i.e.,
vitamin C and vitamin A) in association with glaucoma has been analyzed, but with mixed results. Genetic factors may
play a role in modulating the effect of dietary antioxidant intake on glaucoma; however, nutrigenetic studies in this field
are scarce. Our aim was to study the association between selected polymorphisms in key proteins related to vitamin C and
vitamin A concentrations and primary open-angle glaucoma (POAG).
Methods: We performed a case-control study matched for age, sex, and bodyweight. We recruited 300 subjects (150
POAG cases and 150 controls) from a Mediterranean population and determined the plasma concentrations of vitamin C
and vitamin A for each subject. We selected the following single-nucleotide polymorphisms (SNPs) in genes related to
vitamin A and vitamin C concentrations: rs176990 and rs190910 in the retinol-binding protein 1 (RBP1) gene; and
rs10063949 and rs1279683 in the Na+-dependent L-ascorbic acid transporters 1 and 2, respectively (encoded by the
SLC23A1 and SLC23A2 genes).
Results: We found a statistically significant association between the rs1279386 (A>G) SNP in SLC23A2 and POAG risk.
In the crude analysis, homozygous subjects for the G allele (GG subjects) had higher risk of POAG than other genotypes
(OR: 1.67; 95% CI: 1.03–2.71). This association remained statistically significant (p=0.010) after multivariate adjustment
for potential confounders. We also found that POAG patients had lower plasma vitamin C concentrations than control
subjects (9.9±1.7 µg/ml versus 11.7±1.8 µg/ml, p<0.001). Moreover, we consistently detected a significant association
between the rs1279386 SNP in SLC23A2 and plasma vitamin C concentrations: GG subjects had significantly lower
plasma vitamin C concentrations than the other genotypes (9.0±1.4 µg/ml versus 10.5±1.6 µg/ml, p<0.001 in POAG cases
and 10.9±1.6 µg/ml versus 12.1±1.8 µg/ml, p<0.001 in controls). The rs10063949 SNP in SLC23A1 was not associated
with either plasma vitamin C concentrations or POAG risk. Similarly, SNPs in RBP1 were not associated with vitamin A
concentrations or POAG risk.
Conclusions: The rs1279683 SNP in SLC23A2 was significantly associated with lower plasma concentrations of vitamin
C and with higher risk of POAG in GG subjects.
Glaucoma is a group of diseases in which the optic nerve
is damaged, leading to blindness. The most common form is
primary open-angle glaucoma (POAG) [1]. The main cause
of developing POAG is alteration in the eye tissues, of the
anterior chamber, involved in intraocular pressure (IOP)
regulation, resulting in aqueous humor (AH) outflow
impairment and ocular hypertension (OHT) [2]. Many factors
have been associated with an increased risk of developing this
disease, including age, race, myopia, family history, and
several single-nucleotide polymorphisms (SNPs) in the genes
[3-8].
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Among the non-genetic factors that may be associated
with this optic neuropathy, those related to nutrition have
recently been emerging, but their importance is still unknown.
Recent studies suggest that nutritional factors may play a role
in the pathogenic mechanisms of glaucoma [9,10], and that
these factors could be related to modifications in the trabecular
meshwork (TM; vitamin C, glutathione) and to optic atrophy
(vitamin E) [11]. Because vitamins such as A and C might be
involved in the progression of glaucomatous optic
neuropathy, the nutritional status of patients is very important
in maintaining good eye health [12,13]. Moreover, from a
nutrigenetic point of view, SNPs can modulate the effect of
dietary intake on POAG risk, but this field remains
unexplored.
Vitamin A (retinol) is an essential nutrient in maintaining
ocular health. This vitamin plays a key role in the development
and proper functioning of vision (retinol helps maintain cells
and eye tissues, such as the retina) and prevents eye diseases
Molecular Vision 2011; 17:2997-3004 <http://www.molvis.org/molvis/v17/a323>
Received 27 July 2011 | Accepted 9 November 2011 | Published 17 November 2011
© 2011 Molecular Vision
2997
[14,15]. A lack of vitamin A can lead to serious ocular
problems: loss of visual acuity after dark, dryness of the
conjunctiva, inflammation of the eyelids, and corneal
ulceration [16,17]. One of the genetic factors related to the
metabolism and functions of vitamin A, cellular retinol-
binding protein type 1 (CRBP1), which is encoded by the
retinol-binding protein gene (RBP1), serves to safeguard
retinol homeostasis [18].
Vitamin C is an important water-soluble antioxidant
[19]. Its adequate consumption may prevent the development
of eye diseases, especially degenerative ones, like glaucoma.
With regard to this, a recent study found that serum
concentrations of vitamin C were significantly lower in
glaucoma patients than in healthy controls [20]. Plasma
concentrations of vitamin C are determined by dietary intake,
as well as by genetic factors. L-Ascorbic acid obtained from
the diet is transported across the cell membrane by sodium L-
ascorbic acid cotransporters (SVCTs). Two isoforms, SVCT1
(encoded by the SLC23A1 gene) and SVCT2 (encoded by the
SLC23A2 gene), play central roles in the absorption and
accumulation of vitamin C in many tissues [21,22].
Thus, the aim of this study was to investigate the
association of selected SNPs in RBP1, SLC23A1, and
SLC23A2 with POAG and to test whether this potential effect
was mediated by the association of these polymorphisms with
plasma concentrations of vitamins A and C.
METHODS
Subjects and study design: We performed a matched case-
control study, in which the same number of POAG subjects
and control subjects from a Mediterranean population were
paired by gender, age (±2 years), and body mass index (BMI;
categorized into normal weight, overweight, and obese
subjects). We recruited 300 Caucasian participants (150
patients with POAG, 61 men and 89 women, with mean age
68±9 years; and 150 controls) from two health centers in the
city of Valencia (Spain): the University Hospital Dr. Peset,
Valencia (Department of Ophthalmology and Department of
Preventive Medicine & Public Health) and the School of
Medicine of the University of Valencia (Department of
Preventive Medicine & Public Health). Review boards and
ethical committees of the University of Valencia approved the
protocols for this study, which complied with the Helsinki
guidelines on human research. Informed consent forms were
signed by all study participants.
Cases were subjects with POAG diagnosed by an
ophthalmologist and were aged from 50 to 80 years. Controls
were subjects without ocular diseases (POAG, cataracts, age-
related macular degeneration, or severe myopia) and were
matched with POAG cases by sex, age, and BMI. Cases with
ocular diseases other than POAG, such as rickets,
osteoporosis and osteomalacia, and/or aged outside the range
of inclusion were excluded. Controls with rickets,
osteoporosis or osteomalacia; aged outside the range of
inclusion; and/or with a family history of glaucoma were
excluded. POAG patients underwent a systematized
ophthalmic examination, including slit lamp biomicroscopy,
IOP measurement (with Goldmann applanation tonometry),
best corrected visual acuity, visual field performance (using
the 24–2 Swedish Interactive Threshold Algorithm [SITA;
Humphrey Field Analyzer II; Carl Zeiss Meditec, Inc.,
Dublin, CA]), ocular imaging analysis (using optical
coherence tomography [Stratus OCT; Carl Zeiss Meditec,
Inc.]), and dilated stereoscopic fundus examination under a
78- diopters (D) lens with simultaneous optic disc
photographs. Data on duration of the disease, family
background, therapy, and various aspects of the
ophthalmological examination were registered using a self-
designed database. IOP was also measured in healthy controls.
POAG cases and controls completed a questionnaire
regarding socio-demographic, clinical, and lifestyle variables.
Biochemical and genetic analysis: Global standards for
patient biosample workflow, transport, storage, and
proceedings were strictly followed. In both POAG cases and
controls, whole blood samples were obtained from the
antecubital veins of the participants under fasting conditions
(10–11 h). Blood was collected into EDTA tubes (two 5-ml
tubes per subject, one for DNA extraction and the other for
obtaining plasma).
Genomic DNA was extracted from blood with the
MagNA Pure LC DNA Isolation Kit (Life Sciences Corp.,
Branford, CT). Genotyping of the following SNPs was
performed on a 7900HT Sequence Detection System (Applied
Biosystems, Foster City, CA) using standard TaqMan
fluorescent allelic discrimination assays: rs176990 and
rs190910 in RBP1, rs10063949 in SLC23A1, and rs1279683
in SLC23A2.
Plasma concentrations of vitamin C were measured using
the method of Li et al. [23]. Briefly, analyses were performed
using Shimadzu Scientific Instruments (SSI, Columbia, MD)
equipment with an LC-20AB delivery pump and a Coulochem
III (ESA, Chelmsford, MA) electrochemical detector, under
reversed phase conditions with a 4.6×250 mm, 5 µM YMC-
Pack ODS-AQ column (Waters Corp., Milford, MA). The
software used was LabSolutions 1.2 (SSI, Columbia, MD).
Compounds were eluted over an 18-min runtime at a flow rate
of 0.6 ml/min. The mobile phase consisted of methanol/
150 mM chloroacetate (3:97, v/v) and 2mM disodium EDTA
(pH adjusted to 3.0 with 10 N NaOH). Sample injection was
5 µl.
Vitamin A plasma concentrations were measured
according to the method of Ortega et al. [24], with
modifications. Briefly, analyses were performed in a Gilson
Medical Electronics HPLC system (Middleton, WI) with an
LC307 delivery pump, an LC142 electrochemical detector
(325 nm), and a Shim-pack CLC-ODS C18 column
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(250 mm×6 mm). Compounds were eluted over a 20-min
runtime at a flow rate of 1 ml/min. The mobile phase consisted
of methanol/water (95:5, v/v), and sample injection was 50 µl.
Statistical analysis: Pearson’s χ2 test was used to compare
categorical variables and to check Hardy–Weinberg
equilibrium (HWE) for the analyzed SNPs. The normal
distribution of continuous variables was checked first. These
variables were analyzed using the Unpaired Student’s t-test (2
groups), and the ANOVA test with post-hoc Bonferroni
correction was used (for more than 2 groups) to compare mean
differences among the groups. To estimate the risk of
glaucoma associated with the genotypes, logistic regression
models were fitted, and the odds ratios (OR) and their 95%
confidence intervals (CI) were estimated. Univariate and
multivariate regression models were also fitted, including
control for potential confounders (sex, age, BMI, tobacco
smoking, and alcohol drinking). Multivariate lineal regression
models were used to adjust continuous variables (vitamin
concentrations) for the potential confounders. The original
significance level was set at a p-value of 0.05 by a two-tailed
test, with the Bonferroni correction applied to compensate for
multiple comparisons. This approach consists of using an
adjusted alpha level equal to the original alpha level (0.05),
divided by the number of SNPs analyzed. In our case, the
adjusted alpha is 0.05/4=0.0125. The significance of each
uncorrected test was assessed at this level. PASW software
(version 17.0, SPSS, Inc., Chicago, IL) and the program
Haploview 3.32 were used for statistical analysis.
RESULTS
The general characteristics of all 150 POAG patients and their
paired controls are shown in Table 1. Call rates for the
genotyped SNPs (rs176990 and rs190910 in RBP1,
rs10063949 in SLC23A1, and rs1279683 in SLC23A2) were
all 100%. Genotype distributions in the controls exhibited
TABLE 1. GENERAL CHARACTERISTICS OF POAG CASES AND CONTROLS.
Characteristics Cases (n=150) Controls (n=150) p
Females (%) 59.3 59.3 1.000
Age (years) 68±9 68±8 0.973
BMI (kg/m2) 27.5±4.7 27.4±4.9 0.801
Cup disk ratio 0.7 0.3 <0.001*
Smokers (%) 28 22 0.230
Alcohol consumers (%) 74 68 0.252
          *Statistically significant (p<0.0125) differences between cases and controls. BMI: Body mass index.
TABLE 2. GENOTYPIC FREQUENCIES OF THE RBP1, SLC23A1, AND SLC23A2 POLYMORPHISMS IN POAG CASES AND CONTROLS.
   Genotype frequencies (%)      
 Cases (n=150) Controls (n=150)
Gene SNP Alleles*
(1/2)
1/1 1/2 2/2 1/1 1/2 2/2 p1 OR**
(95%CI)
p2 p3
RBP1 rs176990 T/G 25% 43% 32% 19% 48% 33% 0.423 0.97 (0.60–
1.57)
0.972 0.826
RBP1 rs190910 A/T 20% 52% 28% 15% 53% 32% 0.514 0.83 (0.50–
1.36)
0.451 0.315
SLC23A1 rs10063949 T/C 34% 40% 26% 33% 44% 23% 0.727 1.19 (0.71–
2.03)
0.501 0.552
SLC23A2 rs1279683 A/G 20% 41% 39% 17% 55% 28% 0.044 1.67 (1.03–
2.71)
0.038 0.010***
        *Allele 1 is the ancestral allele. Allele 2 is the variant allele. **Odds ratio (OR) and 95% confidence interval (CI) for homozygous
        subjects for the variant allele (2) compared with the reference category (homozygotes and heterozygotes for the ancestral allele).
        p1: Uncorrected p value obtained in the corresponding χ2 test for the comparison of the genotype distribution between cases and
        controls. p2: Uncorrected p value obtained in the crude logistic regression analysis. p3: Uncorrected p value obtained in the
        multivariate logistic regression after adjustment for sex, age, BMI, tobacco smoking, and drinking. ***Statistically significant
        p value (p<0.0125) after the Bonferroni correction for multiple comparisons.
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Hardy–Weinberg equilibrium (p=0.920, p=0.306, p=0.178,
and p=0.195 for rs176990, rs190910, rs10063949, and
rs1279683, respectively). In the POAG cases, all SNPs had p-
values >0.05 except for rs10063949 (p=0.018). Thus, none of
the four SNPs deviated from HWE in POAG cases after
Bonferroni correction for multiple comparisons
(p>0.05/4=0.0125).
Table 2 shows the genotype frequencies of the four SNPs
in POAG cases and controls. For each SNP, we have first
indicated the genotypes for the ancestral allele, which was the
major allele only for rs10063949. In this population, the
ancestral allele was the minor allele for the other three SNPs.
After evaluation of the genotype distributions, and taking into
account the p-value obtained in the comparisons between
cases and controls, we grouped homozygous and
heterozygous subjects for the ancestral allele and compared
this group with homozygous subjects for the non-ancestral
(variant) allele. OR and 95% CI were estimated for each SNP.
The group of homozygous and heterozygous subjects for the
ancestral allele was considered as the reference category.
Crude and multivariate adjusted p-values were estimated
(Table 2). The crude risk (OR) of POAG associated with the
GG genotype of SLC23A2 in comparison with AA + AG
subjects was 1.67 [95% CI (1.03–2.71), p=0.038]. After
adjustment for potential confounders (sex, gender, BMI,
tobacco smoking, and alcohol consumption), this estimation
reached statistical significance (p=0.010), taking into account
the significance of the threshold p-value (p=0.0125) after the
correction for multiple comparisons. We did not find any
significant association for the other SNPs.
We also analyzed the plasma concentrations of vitamin
C and A for significant differences between cases and
controls. Although plasma concentrations of vitamin A tended
to be lower in POAG patients than in control subjects,
differences did not reach statistical significance (519.3±47.1
ng/ml in POAG cases versus 527.7±58.9 ng/ml in controls;
p=0.174; Figure 1). However, plasma concentrations of
vitamin C were significantly lower in POAG patients than in
controls (9.9±1.7 µg/ml versus 11.7±1.8 µg/ml; p<0.001;
Figure 2).
In addition, we tested the polymorphisms in the vitamin
C cotransporters for association with plasma vitamin C
concentrations (Table 3). In both POAG cases (p<0.001) and
controls (p=0.001), we found a strong association between
rs1279683 in SLC23A2 and plasma vitamin C concentrations.
We also observed that homozygous subjects for the G allele
of rs1279683 in SLC23A2 (GG) had significantly lower
(p<0.001) vitamin C concentrations than carriers of the
ancestral allele (AA + AG). This association remained
statistically significant (p<0.0125) even after multivariate
adjustment for potential confounders (sex, age, BMI,
smoking, and drinking). These results agreed with our
Figure 1. Plasma concentrations of
vitamin A (ng/ml) in POAG cases and
controls. Differences between means in
cases and controls were not statistically
significant (p>0.05).
Molecular Vision 2011; 17:2997-3004 <http://www.molvis.org/molvis/v17/a323> © 2011 Molecular Vision
3000
previous observation when analyzing the association between
rs1279683 and POAG risk. Moreover, the association of
rs1279683 with higher POAG risk was mediated by the SNP’s
association with lower plasma vitamin C concentrations,
given that after multivariate adjustment for plasma vitamin C
concentrations, rs1279683 did not reach statistical
significance in the logistic regression model (OR: 0.73; 95%
CI: 0.41–1.29; p=0.277).
We did not observe any significant association between
the SNP in SLC23A1 and plasma vitamin C concentrations, or
between the SNPs in RBP1 and plasma vitamin A
concentrations (Table 3).
DISCUSSION
The present study has revealed for the first time a significant
association between the rs1279683 (A>G) single-nucleotide
polymorphism (SNP) in SLC23A2 and higher risk of POAG
in homozygous carriers for the G allele (GG). The association
of POAG risk with this SNP appears to be affected by its
influence in determining plasma vitamin C concentrations, as
homozygous carriers of the G allele have significantly lower
plasma vitamin C concentrations than the other genotypes. As
far as we know, this is also the first time that a significant
association between the rs1279683 polymorphism in
SLC23A2 and plasma vitamin C concentration has been
reported in humans. Previous works have demonstrated the
relevance of this gene in animal models and cultured cells
[25,26]. Although rs1279683 is an intronic SNP, functional
assays of this variant have not been performed and it could be
in linkage disequilibrium with the causal variant, if we take
into account our observed results in terms of lower plasma
vitamin C concentrations in homozygous subjects for the G
allele, we can hypothesize that the G allele could be associated
with lower expression of SLC23A2.
Regarding the rs10063949 polymorphism in SLC23A1,
we did not find differences in genotype distribution between
the POAG patients and the control group. Although both
SLC23A1 and SLC23A2 codify for two isoforms of the sodium
L-ascorbic acid cotransporters, and both have important
functions related to ascorbic acid metabolism, SLC23A1 is
expressed in the digestive, reproductive, and urinary system
(not in the visual system). In contrast, SLC23A2 is highly
expressed in the eye [27,28], and our results are in agreement
with this tissue specificity. On the other hand, genetic
variations in the vitamin C transporter SLC23A2 have been
associated with several types of cancer [29-31], supporting the
relevance of this gene in antioxidant mechanisms.
Several authors have demonstrated the existence of
oxidative stress processes in POAG [32-34]. The cause of this
phenomenon is an imbalance between production of free
Figure 2. Plasma concentrations of
vitamin C (µg/ml) in POAG cases and
controls. *Statistically significant
(p<0.0125) differences of means
between cases and controls.
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radicals and antioxidant defenses, so that the body is unable
to inhibit the cellular damage caused by reactive oxygen
species (ROS).
Izzotti et al. [35], by measuring an increase in 8-
hydroxy-2'-deoxyguanosine, demonstrated the occurrence of
oxidative DNA damage in the trabecular meshwork (TM). In
addition, oxidative stress also appears to be related to the
neuronal death characteristic of POAG [36]. We observed
significantly lower plasma levels of vitamin C in POAG
patients than in healthy subjects. These results agree with
those of Yuki et al. [20], who found lower serum levels of
vitamin C in normal-tension glaucoma patients. Leite et al.
[37] studied the ascorbic acid concentration in the secondary
aqueous humor of glaucomatous patients, and found that it
was approximately twofold lower in comparison with the
primary AH of glaucomatous and cataract patients. This
reduction in ascorbic acid (vitamin C) concentration in
glaucoma patients is logical, since this vitamin has a high
antioxidant activity, and subjects with primary open-angle
glaucoma lack this capacity.
The other antioxidant vitamin studied, vitamin A, is very
important in maintaining ocular health and preventing
problems like vision loss, twilight blindness, cataracts,
xerophthalmia, and glaucoma [17]. In our study, although the
plasma vitamin A concentrations tended to be lower in POAG
patients than in controls, this difference was not statistically
significant. The higher complexity of vitamin A metabolism
over that of vitamin C may contribute to the observed results.
In agreement with our results, Yuki et al. [20] did not find
statistically significant differences in plasma vitamin A
concentration between glaucoma patients and controls. In the
present study, we also investigated two SNPs in RBP1. RBP1
is one of the carrier proteins involved in the transport of
retinol. It is highly expressed in the eye and influences
photoreceptor outer segment assembly through a mechanism
unrelated to rhodopsin regeneration [38]. However, we did not
find significant associations with plasma vitamin A
concentration in terms of the studied SNPs, rs176990 and
rs190910.
In conclusion, the results of our study support the
important role of dietary intake of antioxidants, and certain
genetic polymorphisms that modulate their effects, in POAG
risk. Specifically, our results show that low plasma
concentrations of vitamin C, and SNP rs1279683 in
SLC23A2 through its significant association with low plasma
vitamin C concentrations, are POAG risk factors. More
nutrigenetic studies are required to confirm this association in
other populations, as well as to obtain further knowledge on
new gene–diet interactions in POAG pathology.
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